Greenberg Arthur 4
4 · GALECTIN THERAPEUTICS INC · Filed Jul 20, 2012
Insider Transaction Report
Form 4
Greenberg Arthur
Director
Transactions
- Purchase
Common Stock
2012-07-18$1.84/sh+5,000$9,200→ 94,667 total
Footnotes (1)
- [F1]The reporting person in a Form 4 filed on April 18, 2012, voluntarily reported a purchase of the issuer's common stock on April 17, 2012, that was a small acquisition within the meaning of Rule 16a-6 under the Exchange Act that qualified for deferred reporting on Form 5. Had the reporting person elected deferred reporting under Rule 16a-6 for the April 17, 2012 purchase, such purchase when aggregated with the purschase reported herein would have triggered a Form 4 report pursuant to Rule 16a-6(a)(1), but insofar as it has been previously reported, the prior purchase, to avoid confusion, is not included in this report.